Eli Lilly logo is shown on one of the company's offices in San Diego, California, U.S., September 17, 2020.Pharmaceutical company Eli Lilly warning in an open letter on Thursday about the dangers of fake and compounded versions of its diabetes and weight loss medications Mounjaro and Zepbound.
Eli Lilly's main competitor, Novo Nordisk, which sells Ozempic and Wegovy, has also filed lawsuits against med spas purportedly selling knockoff versions. An injection pen of Zepbound, Eli Lilly's weight loss drug, is displayed in New York City, U.S., December 11, 2023.MORE: Drugmaker takes stand against using popular drugs for ‘cosmetic weight loss’
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more: